| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $273.8M | -9.5% |
| Cost of Revenue | $226.2M | -9.2% |
| Gross Profit | $47.6M | -10.7% |
| R&D Expense | $1.4M | -26.3% |
| SG&A Expense | $33.4M | -8.8% |
| Operating Income | $14.2M | -14.8% |
| Interest Expense | $1K | +100.5% |
| Pre-tax Income | $14.7M | -16.0% |
| Income Tax | $3.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.1M | -9.0% |
| Accounts Receivable | $30.8M | +2.4% |
| Inventory | $19.7M | +7.5% |
| Current Assets | $103.3M | +0.4% |
| Total Assets | $228.1M | +8.9% |
| Current Liabilities | $34.2M | -6.9% |
| Long-term Debt | $17.6M | -10.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.2M | -45.4% |
| Capital Expenditures | $17.3M | +49.8% |
| Investing Cash Flow | -$17.3M | -49.8% |
| Financing Cash Flow | -$5.7M | +4.5% |
| Free Cash Flow | $1.9M | -91.9% |
| -16.7% |
| Net Income | $11.2M | -15.8% |
| EPS (Basic) | $1.31 | -14.4% |
| EPS (Diluted) | $1.29 | -14.6% |
| Total Liabilities |
| $70.0M |
| +12.5% |
| Stockholders' Equity | $158.2M | +7.3% |